Based on the clinical findings of our patients carrying the BMPR2 and KDR variants, we hypothesize that these genes might play a role not directly in the development of CTEPH but rather in the progression and severity of the disease. The gene discussed is KDR; the disease is chronic thromboembolic pulmonary hypertension.